Introduction {#s1}
============

The destruction of the World Trade Center (WTC) released massive amounts of dust and fumes into the surrounding environment. Community members, as well as rescue and recovery workers, had acute exposure to the initial dust clouds from the collapsing buildings and/or chronic exposure from resuspended dust or from fumes produced by fires that burned for months \[[@C1], [@C2]\]. Although spirometry has been used to detect lung disease in WTC dust exposed populations, abnormalities have been identified in only a minority of subjects despite development of new-onset and persistent respiratory symptoms. Thus, this population of subjects exposed to WTC dust provided the opportunity to assess the utility of additional screening tests to assess the relationship between the presence and severity of lower respiratory symptoms and functional abnormalities.

Subjects exposed to WTC dust are at risk for development of airway injury at locations ranging from the upper airway to the distal or small airways. Although only 1--2% of outdoor dust consisted of particles \<2.5 μm \[[@C1]\], the extremely large mass of material (∼10^6^ t) suggested potential for small, as well as large, airway exposure to particulate matter. Indoor dust was composed of an even greater concentration of smaller particles; more than 50% of particles had diameters \<53 μm \[[@C3]\]. Analysis of pathological specimens and induced sputum revealed particles ranging in size from 1 to 50 μm, confirming inhalation of particles into peripheral airways \[[@C4]--[@C6]\].

Although spirometry values were normal in the majority of subjects exposed to WTC dust, airway disease was suggested by longitudinal loss of lung function in firefighters, bronchial hyperreactivity, improvement in lung function in a treatment programme, and/or by airway thickening and air trapping seen with radiologic imaging \[[@C7]--[@C10]\]. The absence of an association between spirometry and symptoms in these patients may reflect the limitation of spirometry in detecting functional abnormalities in the small airways (silent zone) of the lung \[[@C11]--[@C13]\]. Despite difficulty in identifying small airway abnormalities, their importance in producing respiratory symptoms has been increasingly recognised \[[@C14]\].

The forced oscillation technique (FOT) is a noninvasive test that measures the relationship between pressure and airflow fluctuations applied externally to the respiratory system. FOT has been utilised to provide information about the small airways in patients with asthma and chronic obstructive lung disease \[[@C15]--[@C18]\]. We previously demonstrated abnormalities consistent with small airway dysfunction in a case series of WTC dust exposed individuals \[[@C19]\]. This finding was confirmed and reinforced in a large case--control study of community members, in which new-onset and persistent lower respiratory symptoms were associated with both the degree of WTC dust exposure and FOT abnormalities \[[@C20], [@C21]\].

We hypothesised that small airway abnormalities undetected by spirometry would be demonstrable in a general clinic population seeking evaluation for respiratory symptoms and that the magnitude of the small airway dysfunction would be related to the severity of the respiratory symptoms.

Methods and materials {#s2}
=====================

Study participants {#s2a}
------------------

Two groups of participants were studied (symptomatic and asymptomatic cohorts). The symptomatic cohort was recruited from the Bellevue Hospital WTC Environmental Health Center (EHC), a clinic initiated in 2005 for community members with physical or mental health symptoms following WTC dust exposure, which has been previously described \[[@C22]\]. Data were analysed from patients who gave consent for entry in a registry approved by the Institutional Review Board (IRB) of New York University School of Medicine (IRB number 06--1). All individuals underwent a standardised evaluation including a multidimensional symptom and exposure questionnaire, spirometry and FOT assessments. The questionnaire has been adapted from standardised instruments for use following exposure to WTC dust to describe lower respiratory symptoms in terms of severity, onset after September 11, 2001 (9/11), persistence over time, and recent occurrence/frequency \[[@C23]\]. Lower respiratory symptoms were defined as wheeze, dyspnoea, chest tightness or cough that were of new onset after 9/11. Individuals were excluded if they were \<18 years old, had lung disease or respiratory symptoms prior to 9/11, or had ≥5 pack-year tobacco use.

Since the majority of patients in the WTC EHC reported symptoms following 9/11, a population of exposed but asymptomatic subjects was obtained from an external published cohort for comparison \[[@C20], [@C21]\]. This population included WTC dust exposed residents or local workers enrolled in the New York City Department of Health and Mental Hygiene WTC Health Registry who were asymptomatic for cough, wheezing or shortness of breath before 9/11 and remained asymptomatic on three occasions 2--7 years after 9/11 (n=475). Individuals gave consent under a protocol approved by the IRB of the New York University School of Medicine (IRB number s13-00426). These subjects were never smokers and had no history of cardiopulmonary disease prior to 9/11. These subjects comprised the asymptomatic cohort.

Lung function measurements {#s2b}
--------------------------

Spirometry was performed according to published standards (Vmax; CareFusion, Yorba Linda, CA, USA) \[[@C24]\]. Data included forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV~1~). Results were classified into normal or abnormal patterns for each patient using their race/ethnicity and published lower limits of normal \[[@C25], [@C26]\].

FOT manoeuvers (Jaeger Impulse Oscillation System; Jaeger, Yorba Linda, CA, USA) were performed in accordance with published recommendations as previously described \[[@C10], [@C20], [@C27]\]. Oscillometric measurements were performed in the symptomatic and asymptomatic cohorts with identical equipment for both populations; testing procedures and technician training/supervision was performed by the same investigators. Manoeuvers were performed during tidal breathing in the seated position, with a nose clip in place and with support of the cheeks. A minimum of three trials, lasting 30 s, was performed. Only data from trials with constant tidal volume were analysed. The volume time tracings were inspected to ensure that there were no pauses suggestive of glottis closure and that there was no leak around the mouthpiece \[[@C28]\]. Since the impulse oscillation system analyses 150 impulses over a 30 s measurement, coherence \>0.70 at 5 Hz and 0.85 at 10 Hz were analysed \[[@C10], [@C29], [@C30]\]. Reproducibility between trials (variability \<10%) was required \[[@C19], [@C20]\]. Data included resistance measured at an oscillating frequency of 5 Hz (*R*~5~) and frequency dependence of resistance (FDR) calculated as the difference between resistance at 5 Hz and 20 Hz (*R*~5−20~). FDR provides a measure of nonuniformity of airflow distribution, which may reflect regional functional abnormalities in the small airways \[[@C15], [@C31], [@C32]\]. Oscillometric data were also compared to upper limits of normal derived from published data in normal subjects \[[@C10], [@C15], [@C33]\]. The values for the selected upper limits of normal agree with estimates based on recent publications of normative FOT data \[[@C34], [@C35]\].

Statistical analysis {#s2c}
--------------------

Counts and percentages were calculated for categorical variables. Medians and interquartile range were calculated for continuous variables. Missing values were excluded from calculations. Associations between study cohorts and categorical variables were tested using the Chi-squared test. For univariate analysis, the nonparametric Kruskal--Wallis test was performed comparing oscillometric values in the symptomatic and asymptomatic cohorts. Multivariate logistic regressions were adopted to assess the association of symptom status with oscillometric measures adjusting for age, body mass index (BMI), race and dust cloud exposure. Relationship between oscillometric values to wheezing severity was analysed by the Jonckheere--Terpstra test to assess the trend of FOT measures across ordered wheezing severity/frequency classes. Analyses were conducted using SAS, version 9.1 (SAS Institute, Cary, NC, USA).

Results {#s3}
=======

Patient characteristics {#s3a}
-----------------------

Between August 2005 and March 2009, valid spirometry and oscillometry data were obtained from 1750 subjects enrolled in the WTC EHC. Subjects were excluded for lung disease or respiratory symptoms preceding 9/11 (n=400), for a ≥5-pack-year tobacco history (n=266) or for absence of any lower respiratory symptoms in the month preceding enrolment (n=236). The remaining 848 subjects reported both new-onset lower respiratory symptoms after 9/11 and symptoms that were persistent in the month preceding enrolment. This group comprised the WTC EHC symptomatic cohort ([figure 1](#F1){ref-type="fig"}). The asymptomatic cohort comprised enrolees in the WTC Health Registry who reported being asymptomatic for persistent cough, wheezing and shortness of breath, and had valid spirometry (n=467) and oscillometry data (n=441). FIGURE 1Flow diagram of patient identification for analysis.

[Table 1](#TB1){ref-type="table"} shows the demographic characteristics of the asymptomatic and symptomatic cohorts. Women comprised almost 50% of both groups. Subjects in the symptomatic cohort were more likely to be Hispanic or African American (p\<0.0001), older (p\<0.03), and overweight (BMI 25--29.9 kg·m^−2^) or obese (BMI ≥30 kg·m^−2^) (p\<0.001), compared to the asymptomatic cohort. Individuals in the symptomatic cohort were also more likely to have been caught in the initial dust clouds created by the collapse of the WTC towers (p\<0.0005). TABLE 1Demographic characteristics of asymptomatic and symptomatic cohorts**CharacteristicAsymptomatic cohortSymptomatic cohortp-valueSubjects n**475848**Sex** Male233 (49)413 (49)[ns]{.smallcaps} Female242 (51)435 (51)**Race/ethnicity** Hispanic22 (5)224 (26)\<0.001 African American22 (5)146 (17) Caucasian/Asian427 (91)478 (56)**Age years** 21--39145 (31)205 (24)\<0.05 40--59267 (56)504 (59) \>5963 (13)139 (16)**BMI kg·m^−2^** \<25274 (58)223 (26)\<0.001 25--30136 (29)345 (41) \>3062 (13)280 (33)**Dust cloud** No306 (65)458 (55)\<0.001 Yes167 (35)377 (45)[^1]

Lung function measurements {#s3b}
--------------------------

Spirometry results are shown in [table 2](#TB2){ref-type="table"}. Median values for FEV~1~ and FVC (expressed as % predicted) for both the asymptomatic and symptomatic cohorts were within normal predicted ranges \[[@C26]\]. However, significantly lower values were noted in the symptomatic compared to the asymptomatic cohort (p\<0.0001) after adjustment for age, race, BMI and dust cloud exposure. FEV~1~/FVC did not differ between the groups. TABLE 2Spirometry results for the asymptomatic and symptomatic cohorts**Asymptomatic cohort**^\#^**Symptomatic cohortp-valueSpirometry parameters median (interquartile range)** FEV~1~ % predicted98.2 (16.7)91.4 (19.7)\<0.0001 FVC % predicted99.4 (15.6)92.3 (20.4)\<0.0001 FEV~1~/FVC %79.3 (8.2)80.0 (8.0)[ns]{.smallcaps}**Spirometry pattern n (%)** Normal409 (87.6)621 (73.2)\<0.0001 Obstructed30 (6.4)60 (7.1)[ns]{.smallcaps} Low FVC26 (5.6)147 (17.3)\<0.0001 Obstructed and low FVC2 (0.4)20 (2.4)\<0.01[^2]

Spirometry patterns are shown in [table 2](#TB2){ref-type="table"}. For the asymptomatic cohort, the majority of subjects demonstrated normal spirometry and the percentage of subjects with abnormal spirometry patterns was in accord with expectations for a healthy population. For the symptomatic cohort, the majority of subjects (73.2%) demonstrated normal spirometry despite persistent respiratory symptoms. Abnormal spirometry pattern was noted in only 27% of the symptomatic cohort and the predominant abnormality was a low FVC pattern, in accord with prior publications in WTC-exposed individuals. The rate of abnormal spirometry was significantly different in the symptomatic compared to the asymptomatic cohort (p\<0.0001), with the proportion of subjects with a low FVC pattern being significantly higher in the symptomatic cohort (17% *versus* 6%, p\<0.0001).

Oscillometry results are shown in [table 3](#TB3){ref-type="table"}. Both *R*~5~ and *R*~5−20~ were elevated in the symptomatic compared to the asymptomatic cohort (p\<0.0001). Since obesity is associated with abnormal oscillometry \[[@C20], [@C36]\], we examined oscillometric parameters in the asymptomatic and symptomatic WTC EHC Cohorts after stratifying by BMI category ([figure 2](#F2){ref-type="fig"}). As anticipated, median *R*~5~ and *R*~5−20~ increased with increasing BMI in both groups. Despite the increase in FOT measurements with BMI, median values for *R*~5~ and *R*~5−20~ were significantly higher in the symptomatic compared with the asymptomatic cohort across all BMI categories (p\<0.0001 for all comparisons). FIGURE 2a) Resistance at an oscillating frequency of 5 Hz (*R*~5~) and b) difference in resistances measured at 5 and 20 Hz (*R*~5−20~) are plotted by body mass index (BMI) status for the asymptomatic *versus* symptomatic cohorts. Boxes represent 25th, 50th and 75th percentiles for *R*~5~ and *R*~5−20~ distribution. Whiskers represent fifth and 95th percentiles. TABLE 3Oscillometry results for the asymptomatic and symptomatic cohorts**Oscillometry parametersUpper limit of normalAsymptomatic cohort**^\#^**Symptomatic cohortp-value*R***~**5**~ **kPa·L^−1^·s^−1^**0.3880.318 (0.140)0.450 (0.228)\<0.01***R***~**5−20**~ **kPa·L^−1^·s^−1^**0.0750.005 (0.043)0.081 (0.099)\<0.01[^3]

Oscillometry measurements in subjects with a normal spirometry pattern {#s3c}
----------------------------------------------------------------------

Oscillometric parameters were analysed in the cohorts after categorising subjects based on their initial spirometry results. [Figure 3](#F3){ref-type="fig"} illustrates oscillometric data from subjects with normal spirometry in the asymptomatic and symptomatic cohorts. Despite spirometry measurements within normal limits, median *R*~5~ remained elevated in the symptomatic compared to the asymptomatic cohort (median (interquartile range) 0.436 (0.206) *versus* 0.314 (0.129) kPa·L^−1^·s^−1^, p\<0.0001). Similar results were demonstrated for *R*~5−20~ in subjects with normal spirometry (0.075 (0.085) *versus* 0.004 (0.042) kPa·L^−1^·s^−1^, p\<0.0001). When data were analysed with respect to the upper limit of normal, elevated *R*~5~ and *R*~5−20~ were noted in the majority of subjects despite normal spirometry (62% and 50%, respectively). In contrast, analysis of midexpiratory airflow rates demonstrated abnormal values in only 14% of these subjects. FIGURE 3a) Resistance at an oscillating frequency of 5 Hz (*R*~5~) and b) difference in resistances measured at 5 and 20 Hz (*R*~5−20~) are plotted for individuals with normal spirometry from the asymptomatic *versus* symptomatic cohorts. Boxes represent 25th, 50th and 75th percentiles for *R*~5~ and *R*~5−20~ distribution. Whiskers represent fifth and 95th percentiles. p-values were adjusted for age, race and body mass index.

Relationship of symptoms with oscillometry {#s3d}
------------------------------------------

We examined oscillometric measurements and symptom severity in the symptomatic cohort. No relationship was observed between cough and dyspnoea to oscillometry (data not shown); however, a relationship to wheeze was noted ([table 4](#TB4){ref-type="table"}). Wheeze was characterised by self-report of degree of severity (mild, moderate or severe) and frequency in the 4 weeks prior to enrolment. For the symptomatic cohort, a significant trend was demonstrated with increasing values for both *R*~5~ and *R*~5−20~ in relation to increasing severity of wheeze. Similarly, both *R*~5~ and *R*~5−20~ increased in relation to frequency of wheeze (p\<0.01 for all analyses). TABLE 4Severity and frequency of wheeze and impulse oscillometry for the symptomatic cohort**Subjects n*R***~**5**~ **kPa·L^−1^·s^−1^*R***~**5−20**~ **kPa·L^−1^·s^−1^Wheeze severity** None5020.447 (0.212)0.074 (0.087) Mild1370.458 (0.260)0.085 (0.123) Moderate1280.473 (0.233)0.102 (0.121) Severe670.503 (0.301)0.113 (0.129) p-value^\#^0.001\<0.0001**Wheeze frequency days per week** 0--15240.441 (0.220)0.076 (0.088) 2--61940.461 (0.218)0.086 (0.117) 71000.510 (0.278)0.126 (0.122) p-value^\#^\<0.010.0001[^4]

The association of oscillometry measurements with frequency and severity of wheeze was also evaluated in the subgroup of subjects in the symptomatic cohort with normal spirometry ([table 5](#TB5){ref-type="table"}). Increasing values of *R*~5−20~ were significantly associated with increasing severity and frequency of wheeze. In contrast, no association was found between *R*~5~ and either severity or frequency of wheeze~.~ TABLE 5Severity and frequency of wheeze and impulse oscillometry for symptomatic cohort patients with normal spirometry**Subjects n*R***~**5**~ **kPa·L^−1^·s^−1^*R***~**5−20**~ **kPa·L^−1^·s^−1^Wheeze severity** None3840.429 (0.200)0.070 (0.081) Mild970.424 (0.218)0.080 (0.077) Moderate800.457 (0.231)0.078 (0.088) Severe500.496 (0.191)0.097 (0.101) p-value^\#^[ns]{.smallcaps}0.03**Wheeze frequency days per week** 0--14000.432 (0.206)0.071 (0.088) 2--61290.437 (0.216)0.077 (0.069) 7700.492 (0.265)0.100 (0.118) p-value^\#^[ns]{.smallcaps}0.05[^5]

Discussion {#s4}
==========

We examined the utility of adding oscillometry to spirometry in evaluation of new-onset and persistent lower respiratory symptoms in a large cohort of WTC dust exposed community members. Whereas abnormal spirometry was evident in a minority of the WTC EHC symptomatic cohort, oscillometry measurements were abnormal in most. Abnormalities in oscillometry were characterised by elevations in both respiratory resistance (*R*~5~) and FDR (*R*~5−20~). Since the presence of FDR is consistent with nonuniformity of airflow distribution and regional functional abnormalities in the small airways \[[@C15], [@C31], [@C32]\] and since FDR was detected even when spirometry was within normal limits, these data suggest isolated injury to the small airways in many of these symptomatic subjects. Importantly, oscillometry measurements increased with both severity and frequency of wheeze, even when the analysis was limited to those with normal spirometry. These findings suggest that functional abnormalities isolated to the small airways may provide an explanation for presence and severity of lower respiratory symptoms.

An understanding of the physiological abnormalities associated with respiratory symptoms following exposure to WTC dust has been elusive, since the majority of subjects demonstrate normal spirometry and chest radiographs \[[@C7], [@C22], [@C37], [@C38]\]. A role for small airway dysfunction was initially suggested by several studies using forced oscillation \[[@C33]\]. FDR on oscillometry and frequency dependence of compliance on oesophageal manometry was shown in a case series of subjects with exposure to WTC dust \[[@C19]\]. More recently, we linked the development of lower respiratory symptoms to both intensity of WTC dust exposure and abnormal FDR in subjects enrolled in the WTC Health Registry \[[@C20], [@C21]\]. Our current study in the Bellevue Hospital WTC EHC supports and extends these findings by demonstrating evidence for small airway dysfunction not detectable by spirometry (either by FEV~1~ or by midexpiratory airflow rate) in a general population seeking medical care for lower respiratory symptoms following exposure to WTC dust. Moreover, for the subjects with abnormal spirometry in the present study, the predominant abnormality was reduction in vital capacity with normal FEV~1~/FVC, a pattern that has recently been linked to small airway dysfunction following WTC dust exposure \[[@C10]\]. Lastly, the present study reinforces the link between small airway function and symptoms by demonstrating an association between FOT parameters and severity of wheeze.

The abnormalities in oscillometry parameters detected in the WTC EHC symptomatic population are consistent with injury to small airways. Oscillometry parameters included *R*~5~, a measure of respiratory resistance, and *R*~5−20~, a measure of FDR. FDR has been attributed to nonuniform distribution of airflow in the distal lung \[[@C15], [@C31], [@C32]\] and has been shown to correlate with assessment of frequency dependence of compliance using oesophageal manometry \[[@C39], [@C40]\], an established marker of small airway dysfunction. Biological plausibility for small airway injury is supported by demonstration of particles in the lower airways in both pathological specimens and induced sputum \[[@C4]--[@C6]\]. The presence of small airway injury in WTC-exposed populations is further supported by demonstration of air trapping on either computed tomography imaging and/or plethysmography \[[@C7]--[@C9]\]. In addition, pathological specimens have demonstrated objective signs of small airway and parenchymal lung injury \[[@C5]\]. In the present study, abnormal resistance and FDR were demonstrated in the symptomatic cohort. This observation, coupled with the finding that FVC and FEV~1~ remained in the normal range, is consistent with a location of injury that is more distal than that detectable by spirometry. Although FDR may reflect abnormalities in elements of the distal lung unit beyond the airways, the correlation with wheezing indicates a significant component of small airway injury in this cohort.

The present study demonstrated the novel association between oscillometry measurements and self-reported lower respiratory symptoms in the symptomatic cohort \[[@C14]\]. While no relationship was demonstrable for cough or dyspnoea, a strong relationship was seen between magnitude of FDR with both severity and frequency of wheeze, a marker of airway reactivity. These findings are in accord with prior demonstration that elevated blood eosinophils in WTC dust exposed subjects are associated with both the presence and self-reported frequency and severity of wheeze but not with either cough or dyspnoea \[[@C41]\]. Although this prior study demonstrated an association between wheeze and presence of obstruction on spirometry, wheezing was also noted in approximately 33% of subjects with normal spirometry \[[@C41]\]. The present study extends these observations by demonstrating that oscillometry measurements of FDR remained significantly associated with frequency and severity of wheeze in the subjects with normal spirometry. Although these associations do not prove causality, a previous study during methacholine challenge testing demonstrated that the onset of respiratory symptoms during induced bronchoconstriction may occur simultaneous with the onset of small airway abnormalities on FOT testing even when spirometry remains unchanged \[[@C42]\].

This study was designed to examine the link between the respiratory symptoms and physiological abnormalities but not to detailed WTC dust exposure. Previous studies have demonstrated a relationship between severity of WTC dust exposure and/or exposure to the dust cloud, and both development of respiratory symptoms and physiological abnormalities in the small airways \[[@C20], [@C21]\]. In accord with this finding, exposure to the dust cloud was noted more frequently in the symptomatic *versus* the asymptomatic cohort.

There are several limitations to this study. FOT data was not corrected for lung volume and high values for resistance would occur if functional residual capacity (FRC) was reduced. Although FRC was not measured in this study, we previously demonstrated that FRC remained in the normal range following exposure to WTC dust \[[@C19]\]. In addition, while the most likely cause for a reduced FRC in the present study is obesity, it is unlikely to have influenced the conclusions since symptomatic subjects demonstrated higher resistance and more FDR across all categories of BMI. An additional consideration relates to the potential for upper airway abnormalities and/or glottic closure, which could contribute to both symptoms and abnormal FOT \[[@C43]\]. However, in the present study, there was no evidence for upper airway dysfunction on the inspiratory portion of the flow--volume curve and the FOT technique was specifically evaluated to exclude glottis closure during testing \[[@C28]\]. Lastly, an asymptomatic population within the WTC EHC could not be identified because patients were self-referred for evaluation of symptoms. Therefore, we used an external asymptomatic population that had undergone similar measurements as part of a collaborative study of WTC health effects \[[@C20]\]. These subjects either lived or worked in lower Manhattan and may have sustained some exposure to WTC dust. Spirometry and oscillometry measurements were performed within a similar time frame with similar equipment, techniques and personnel. Oscillometry values in this population were within the normal range when compared to published data, supporting that these subjects had normal airway function despite WTC dust exposure \[[@C10], [@C15], [@C33]--[@C35]\]. Although demographic characteristics differed between the symptomatic and the asymptomatic cohort, the difference in oscillometry measurements remained even after adjustment for these differences. Moreover, in analyses limited to the symptomatic cohort, a relationship was observed between the magnitude of small airway dysfunction and severity and frequency of wheeze. Although symptoms in these subjects were assessed by self report, oscillometry measurements are not influenced by patient effort and were obtained independently.

In summary, addition of forced oscillation to routine assessment of spirometry in the clinical setting uncovered abnormalities in lung function in a persistently symptomatic population with normal spirometry many years after exposure to the 9/11 disaster. The present study highlights that assessment of small airway function can be performed routinely in the large-scale clinical setting. Importantly, the study suggests that small airway assessment has an important role in characterising symptoms not explained by spirometry. The finding of abnormal oscillometry and its correlation to symptom severity, even in the setting of normal spirometry, is in accord with the presence of small airway abnormalities as a potential explanation of the lower respiratory symptoms. The presence of small airway abnormality associated with persistence of lower respiratory symptoms many years after exposure to WTC dust suggests persistent airway disease.
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[^1]: Data are presented as n (%) unless otherwise stated. BMI: body mass index; [ns]{.smallcaps}: not significant.

[^2]: FEV~1~: forced expiratory volume in 1 s; FVC: forced vital capacity; [ns]{.smallcaps}: not significant. ^\#^: valid spirometry data were not available in eight subjects from the asymptomatic cohort.

[^3]: Data are presented as median (interquartile range) unless otherwise stated. *R*~5~: resistance at an oscillating frequency of 5 Hz; *R*~5--20~: difference in resistances measured at 5 and 20 Hz. ^\#^: valid data were not available in 34 subjects from the asymptomatic cohort.

[^4]: Data are presented as median (interquartile range) unless otherwise stated. *R*~5~: resistance at an oscillating frequency of 5 Hz; *R*~5--20~: difference in resistances measured at 5 and 20 Hz. ^\#^: Jonckheere--Terpstra test.

[^5]: Data are presented as median (interquartile range) unless otherwise stated. *R*~5~: resistance at an oscillating frequency of 5 Hz; *R*~5--20~: difference in resistances measured at 5 and 20 Hz; [ns]{.smallcaps}: not significant. ^\#^: Jonckheere--Terpstra test.
